back on a team to ride the Tour once more, but Armstrong refused because Landis was a convicted doper. Landis joined OUCH, an American continental team, and not long after this initiated contact with USADA to discuss Armstrong. In 2011, Cadel Evans became the first Australian to win the Tour after coming up just short several times in the previous few editions. Very early in his career while making the transition from mountain biking to pro cycling, Evans met with Armstrong's doctor Michele Ferrari one time, but he never again had professional contact with him. The 2012 Tour de France was won by the first British rider to ever win the Tour, Bradley Wiggins, while finishing on the podium just behind him was Chris Froome, who along with Contador became the next big stars to attempt to contest the giants of Anquetil, Merckx, Hinault, Indurain and Armstrong. Overshadowing the entire sport at this time, however, was the Lance Armstrong doping case, which finally revealed much of the truth about doping in cycling. As a result, the UCI decided that each of Armstrong's seven wins would be revoked. This decision cleared the names of many people, including lesser-known riders, reporters, team medical staff, and even the wife of a rider who had their reputations tarnished or had been forced from the sport by challenging the Armstrong machine. Much of this only became possible after Floyd Landis came forward to USADA. Also around this time, an investigation by the French government into doping in cycling revealed that way back during the 1998 Tour, close to 90% of the riders who were tested, retroactively tested positive for EPO. The result of these doping scandals being that in the case of Landis in 2006, and Contador in 2010, new winners were declared in Óscar Pereiro and Andy Schleck, respectively; however, in the case of the seven Tours revoked from Armstrong, there was no alternate winner named, as much of Armstrong's competition was just as guilty as he was, and the sport at this point was trying to set the right example for the future generation of riders. The generation from the mid-2010s and beyond seems to be competing on a level playing field without having to make the decision so many riders of the previous generation had to make: to give in and start doping to be competitive, or give up on their dreams.